Roxadustat and the Interpretation of Non-Inferiority

freecme000
Published on Nov 29, 2022
CLICK ON LINK BELOW
https://www.asn-online.org/media/podcast/JASN/2022_04_11_JASN2021050681.mp3
Dr. Josie Briggs, discusses a non-inferiority trial on Roxadustat in dialysis patients and explains the interpretation of the finding that roxadustat is non-inferior to epoetin alpha.

Category

Share Podcast

Add to

Flag Podcast

Rate podcast

Rate podcast

Up next
Autoplay